Johnson & Johnson narrowly tops quarterly estimates as pharmaceutical, medtech sales jump

[ad_1]

The results come six months after J&J completed its spinoff of consumer health unit Kenvue, the company's biggest shake-up in its nearly 140-year history.

[ad_2]

Source link